Search for other papers by Karim Gariani in
Google Scholar
PubMed
Search for other papers by Pedro Marques-Vidal in
Google Scholar
PubMed
Search for other papers by Gérard Waeber in
Google Scholar
PubMed
Search for other papers by Peter Vollenweider in
Google Scholar
PubMed
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
Introduction Type 2 diabetes mellitus (T2DM) pathogenesis may involve the hypothalamic–pituitary–adrenal axis (HPA) ( 1 ). Common features observed in T2DM and metabolic syndrome, such as elevated fasting glucose, obesity, hyperlipidemia or
Search for other papers by Yusen Liu in
Google Scholar
PubMed
Search for other papers by Ruiwen Chi in
Google Scholar
PubMed
Search for other papers by Yujie Jiang in
Google Scholar
PubMed
Search for other papers by Bicheng Chen in
Google Scholar
PubMed
Search for other papers by Youli Chen in
Google Scholar
PubMed
Search for other papers by Zengrui Chen in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM), the most common medical disorder in pregnancy, is defined as glucose intolerance resulting in hyperglycemia that begins or is first diagnosed during pregnancy ( 1 ). GDM is associated with
Search for other papers by Changwei Liu in
Google Scholar
PubMed
Search for other papers by Jingwen Wang in
Google Scholar
PubMed
Search for other papers by Yuanyuan Wan in
Google Scholar
PubMed
Search for other papers by Xiaona Xia in
Google Scholar
PubMed
Search for other papers by Jian Pan in
Google Scholar
PubMed
Search for other papers by Wei Gu in
Google Scholar
PubMed
Search for other papers by Mei Li in
Google Scholar
PubMed
Background Type 1 diabetes mellitus (T1DM) is an autoimmune disease occurring in the pancreatic islets. The disease can affect people of any age, but onset usually occurs in children or young adults, which accounts for 90% of diabetes in
Search for other papers by Panisa Hantrakun in
Google Scholar
PubMed
Search for other papers by Rattanaporn Sekararithi in
Google Scholar
PubMed
Search for other papers by Thidarat Jaiwongkam in
Google Scholar
PubMed
Search for other papers by Sirinart Kumfu in
Google Scholar
PubMed
Search for other papers by Chatree Chai-adisaksopha in
Google Scholar
PubMed
Search for other papers by Nipon Chattipakorn in
Google Scholar
PubMed
Search for other papers by Theera Tongsong in
Google Scholar
PubMed
Search for other papers by Phudit Jatavan in
Google Scholar
PubMed
Gestational diabetes mellitus (GDM), one of the most common complications in pregnancy, is defined as glucose intolerance of variable severity with onset or first recognition during pregnancy ( 1 ). GDM usually disappears shortly after birth but up to 50% will
Search for other papers by Metin Guclu in
Google Scholar
PubMed
Search for other papers by Sinem Kiyici in
Google Scholar
PubMed
Search for other papers by Zulfiye Gul in
Google Scholar
PubMed
Search for other papers by Sinan Cavun in
Google Scholar
PubMed
Introduction Excess weight and weight gain are significant problems in the treatment of patients with type 2 diabetes mellitus ( 1 ). Weight reduction is a critical part of type 2 diabetic patients’ management to obtain better glycemic control
Search for other papers by Chenyu Jiang in
Google Scholar
PubMed
Search for other papers by Mi Zhou in
Google Scholar
PubMed
Search for other papers by Huai Bai in
Google Scholar
PubMed
Search for other papers by Meng Chen in
Google Scholar
PubMed
Search for other papers by Chunyi Yang in
Google Scholar
PubMed
Search for other papers by Kaifeng Hu in
Google Scholar
PubMed
Search for other papers by Yujie Wu in
Google Scholar
PubMed
Search for other papers by Qingqing Liu in
Google Scholar
PubMed
Search for other papers by Yangyu Zhao in
Google Scholar
PubMed
Search for other papers by Xinghui Liu in
Google Scholar
PubMed
Search for other papers by Ping Fan in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM) is one of the most common metabolic diseases in obstetrics, characterized by carbohydrate intolerance that develops during pregnancy ( 1 ). Along with the increasing prevalence of obesity
Search for other papers by Hana Vítková in
Google Scholar
PubMed
Department of Gynaecology, Obstetrics and Neonatology, First Faculty of Medicine Charles University and General University Hospital in Prague, Prague, Czech Republic
Search for other papers by Kateřina Anderlová in
Google Scholar
PubMed
Search for other papers by Jan Krátký in
Google Scholar
PubMed
Search for other papers by Radovan Bílek in
Google Scholar
PubMed
Search for other papers by Drahomíra Springer in
Google Scholar
PubMed
Search for other papers by Felix Votava in
Google Scholar
PubMed
Search for other papers by Tomáš Brutvan in
Google Scholar
PubMed
Search for other papers by Adéla Krausová in
Google Scholar
PubMed
Search for other papers by Kristýna Žabková in
Google Scholar
PubMed
Search for other papers by Eliška Potluková in
Google Scholar
PubMed
Search for other papers by Jan Jiskra in
Google Scholar
PubMed
, some studies have pointed to a possible relationship between thyroid dysfunction and/or thyroid autoimmunity and gestational diabetes mellitus (GDM) ( 5 ). Recently, Sitoris et al. ( 6 ) reported that thyroid autoimmunity in euthyroid women is
Search for other papers by Chenghao Piao in
Google Scholar
PubMed
Search for other papers by Xiaojie Wang in
Google Scholar
PubMed
Search for other papers by Shiqiao Peng in
Google Scholar
PubMed
Search for other papers by Xinyu Guo in
Google Scholar
PubMed
Search for other papers by Hui Zhao in
Google Scholar
PubMed
Search for other papers by Li He in
Google Scholar
PubMed
Search for other papers by Yan Zeng in
Google Scholar
PubMed
Search for other papers by Fan Zhang in
Google Scholar
PubMed
Search for other papers by Kewen Zhu in
Google Scholar
PubMed
Search for other papers by Yiwei Wang in
Google Scholar
PubMed
Introduction Insulin sensitivity during pregnancy is reduced with the advancement of gestation. Thus, the demand for insulin is elevated to maintain the common blood sugar ( 1 ). Gestational diabetes mellitus (GDM) is characterized by glucose
Search for other papers by Sweta Budyal in
Google Scholar
PubMed
Search for other papers by Swati Sachin Jadhav in
Google Scholar
PubMed
Search for other papers by Rajeev Kasaliwal in
Google Scholar
PubMed
Search for other papers by Hiren Patt in
Google Scholar
PubMed
Search for other papers by Shruti Khare in
Google Scholar
PubMed
Search for other papers by Vyankatesh Shivane in
Google Scholar
PubMed
Search for other papers by Anurag R Lila in
Google Scholar
PubMed
Search for other papers by Tushar Bandgar in
Google Scholar
PubMed
Search for other papers by Nalini S Shah in
Google Scholar
PubMed
with type 2 diabetes mellitus (T2DM), obesity, osteoporosis, and polycystic ovarian syndrome (PCOS) (4, 5, 6, 7, 8) . As impaired glucose tolerance and diabetes are important metabolic manifestations of CS, several studies have attempted to examine the
Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian Province, China
Search for other papers by Qiuyu Huang in
Google Scholar
PubMed
Search for other papers by Hanshen Chen in
Google Scholar
PubMed
Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian Province, China
Search for other papers by Fan Xu in
Google Scholar
PubMed
Search for other papers by Chao Liu in
Google Scholar
PubMed
Search for other papers by Yafeng Wang in
Google Scholar
PubMed
Search for other papers by Weifeng Tang in
Google Scholar
PubMed
Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian Province, China
Search for other papers by Liangwan Chen in
Google Scholar
PubMed
Introduction Type 2 diabetes mellitus (T2DM) is considered as a metabolic disease with hyperglycemia and vascular and/or nervous complications. In China, the reported prevalence of T2DM is 11.6% ( 1 ), which appears to have increased in the